Mirae Asset Global Etfs Holdings Ltd. Vaxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 76,534 shares of PCVX stock, worth $5.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,534
Previous 65,311
17.18%
Holding current value
$5.61 Million
Previous $7.46 Million
15.97%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$876 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$775 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$728 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$636 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$455 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.34B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...